Have a feature idea you'd love to see implemented?
Let us know!
IVVD Invivyd Inc
Price (delayed)
$0.6998
Market cap
$83.71M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.96
Enterprise value
-$21.53M
Adagio (Nasdaq: ADGI) is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company’s portfolio of antibodies has
Highlights
Invivyd's debt has surged by 140% QoQ but it has decreased by 36% YoY
The quick ratio has plunged by 85% YoY and by 64% from the previous quarter
Invivyd's equity has plunged by 66% YoY and by 41% from the previous quarter
Key stats
What are the main financial stats of IVVD
Market
Valuations
Earnings
Shares outstanding
119.62M
Market cap
$83.71M
Enterprise value
-$21.53M
Price to earnings (P/E)
N/A
Price to book (P/B)
1.01
Price to sales (P/S)
7.23
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
-1.86
Revenue
$11.56M
EBIT
-$225.14M
EBITDA
-$223.02M
Free cash flow
-$192.27M
Per share
Balance sheet
Liquidity
EPS
-$1.96
Free cash flow per share
-$1.61
Book value per share
$0.7
Revenue per share
$0.1
TBVPS
$1.36
Total assets
$161.92M
Total liabilities
$78.76M
Debt
$1.63M
Equity
$83.16M
Working capital
$72.56M
Debt to equity
0.02
Current ratio
1.92
Quick ratio
1.46
Net debt/EBITDA
0.47
Margins
Efficiency
Dividend
EBITDA margin
-1,928.6%
Gross margin
92.3%
Net margin
-1,946.9%
Operating margin
-2,027%
Return on assets
-114.9%
Return on equity
-155.3%
Return on invested capital
N/A
Return on capital employed
-270%
Return on sales
-1,946.9%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
IVVD stock price
How has the Invivyd stock price performed over time
Intraday
-8.89%
1 week
-11.47%
1 month
-31.39%
1 year
-52.39%
YTD
-82.24%
QTD
-31.39%
Financial performance
How have Invivyd's revenue and profit performed over time
Revenue
$11.56M
Gross profit
$10.67M
Operating income
-$234.4M
Net income
-$225.14M
Gross margin
92.3%
Net margin
-1,946.9%
IVVD's operating margin has surged by 79% since the previous quarter
Invivyd's net margin has surged by 78% QoQ
Invivyd's operating income has decreased by 40% YoY and by 9% QoQ
The net income has contracted by 33% YoY and by 10% from the previous quarter
Growth
What is Invivyd's growth rate over time
Valuation
What is Invivyd stock price valuation
P/E
N/A
P/B
1.01
P/S
7.23
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
-1.86
IVVD's EPS is down by 26% year-on-year and by 8% since the previous quarter
Invivyd's equity has plunged by 66% YoY and by 41% from the previous quarter
The price to book (P/B) is 50% lower than the last 4 quarters average of 2.0
Efficiency
How efficient is Invivyd business performance
IVVD's return on equity has dropped by 177% year-on-year and by 42% since the previous quarter
The company's return on assets has shrunk by 124% YoY and by 26% QoQ
IVVD's return on sales has surged by 78% since the previous quarter
Dividends
What is IVVD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for IVVD.
Financial health
How did Invivyd financials performed over time
Invivyd's total assets is 106% more than its total liabilities
IVVD's total liabilities has surged by 177% year-on-year and by 115% since the previous quarter
The quick ratio has plunged by 85% YoY and by 64% from the previous quarter
Invivyd's debt is 98% lower than its equity
Invivyd's debt has surged by 140% QoQ but it has decreased by 36% YoY
Invivyd's debt to equity has surged by 100% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.